Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Zürbig P[au]:

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Siwy J et al. Nephrol Dial Transplant. (2017)

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker. Pontillo C et al. Kidney Int Rep. (2017)

The long path towards implementation of clinical proteomics: Exemplified based on CKD273. Nkuipou-Kenfack E et al. Proteomics Clin Appl. (2017)

Search results

Items: 1 to 50 of 81

1.

Proteomics and personalized medicine: a focus on kidney disease.

Siwy J, Mischak H, Zürbig P.

Expert Rev Proteomics. 2019 Sep;16(9):773-782. doi: 10.1080/14789450.2019.1659138. Epub 2019 Aug 23.

PMID:
31441341
2.

Emerging urine-based proteomic biomarkers as valuable tools in the management of chronic kidney disease.

Zürbig P, Siwy J, Mischak H.

Expert Rev Mol Diagn. 2019 Oct;19(10):853-856. doi: 10.1080/14737159.2019.1657406. Epub 2019 Aug 21. No abstract available.

PMID:
31423855
3.

Apelin affects the mouse aging urinary peptidome with minimal effects on kidney.

Vinel C, Schanstra JP, Boizard F, Péreira O, Auriau J, Dortignac A, Breuil B, Feuillet G, Nkuipou-Kenfack E, Zürbig P, Valet P, Bascands JL, Dray C, Denis C.

Sci Rep. 2019 Jul 23;9(1):10647. doi: 10.1038/s41598-019-47109-4.

4.

Urinary peptidome analyses for the diagnosis of chronic kidney disease in dogs.

Pelander L, Brunchault V, Buffin-Meyer B, Klein J, Breuil B, Zürbig P, Magalhães P, Mullen W, Elliott J, Syme H, Schanstra JP, Häggström J, Ljungvall I.

Vet J. 2019 Jul;249:73-79. doi: 10.1016/j.tvjl.2019.05.010. Epub 2019 May 27.

5.

Urinary proteome signature of Renal Cysts and Diabetes syndrome in children.

Ricci P, Magalhães P, Krochmal M, Pejchinovski M, Daina E, Caruso MR, Goea L, Belczacka I, Remuzzi G, Umbhauer M, Drube J, Pape L, Mischak H, Decramer S, Schaefer F, Schanstra JP, Cereghini S, Zürbig P.

Sci Rep. 2019 Feb 18;9(1):2225. doi: 10.1038/s41598-019-38713-5.

6.

Proteomic Evidence of Biological Aging in a Child with a Compound Heterozygous ZMPSTE24 Mutation.

Lucas-Herald AK, Zürbig P, Mason A, Kinning E, Brown CE, Mansoorian B, Mullen W, Ahmed SF, Delles C.

Proteomics Clin Appl. 2019 Mar;13(2):e1800135. doi: 10.1002/prca.201800135. Epub 2018 Dec 27.

7.

Publisher Correction: Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.

Rodríguez-Ortiz ME, Pontillo C, Rodríguez M, Zürbig P, Mischak H, Ortiz A.

Sci Rep. 2018 Dec 10;8(1):17822. doi: 10.1038/s41598-018-36919-7.

8.

CKD273 Enables Efficient Prediction of Diabetic Nephropathy in Nonalbuminuric Patients.

Zürbig P, Mischak H, Menne J, Haller H.

Diabetes Care. 2019 Jan;42(1):e4-e5. doi: 10.2337/dc18-1322. Epub 2018 Nov 19. No abstract available.

PMID:
30455331
9.

Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.

Rodríguez-Ortiz ME, Pontillo C, Rodríguez M, Zürbig P, Mischak H, Ortiz A.

Sci Rep. 2018 Oct 29;8(1):15940. doi: 10.1038/s41598-018-34386-8. Erratum in: Sci Rep. 2018 Dec 10;8(1):17822.

10.

Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study.

Kanzelmeyer NK, Zürbig P, Mischak H, Metzger J, Fichtner A, Ruszai KH, Seemann T, Hansen M, Wygoda S, Krupka K, Tönshoff B, Melk A, Pape L.

Transpl Int. 2019 Jan;32(1):28-37. doi: 10.1111/tri.13363. Epub 2018 Nov 12.

PMID:
30357927
11.

Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension.

Wallbach M, Zürbig P, Dihazi H, Müller GA, Wachter R, Beige J, Koziolek MJ, Mischak H.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1519-1526. doi: 10.1111/jch.13365. Epub 2018 Sep 10.

12.

Comparison of Urine and Plasma Peptidome Indicates Selectivity in Renal Peptide Handling.

Magalhães P, Pontillo C, Pejchinovski M, Siwy J, Krochmal M, Makridakis M, Carrick E, Klein J, Mullen W, Jankowski J, Vlahou A, Mischak H, Schanstra JP, Zürbig P, Pape L.

Proteomics Clin Appl. 2018 Sep;12(5):e1700163. doi: 10.1002/prca.201700163. Epub 2018 Apr 23.

PMID:
29611317
13.

Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?

Magalhães P, Pejchinovski M, Markoska K, Banasik M, Klinger M, Švec-Billá D, Rychlík I, Rroji M, Restivo A, Capasso G, Bob F, Schiller A, Ortiz A, Perez-Gomez MV, Cannata P, Sanchez-Niño MD, Naumovic R, Brkovic V, Polenakovic M, Mullen W, Vlahou A, Zürbig P, Pape L, Ferrario F, Denis C, Spasovski G, Mischak H, Schanstra JP.

Sci Rep. 2017 Dec 5;7(1):16915. doi: 10.1038/s41598-017-17083-w.

14.

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker.

Pontillo C, Zhang ZY, Schanstra JP, Jacobs L, Zürbig P, Thijs L, Ramírez-Torres A, Heerspink HJL, Lindhardt M, Klein R, Orchard T, Porta M, Bilous RW, Charturvedi N, Rossing P, Vlahou A, Schepers E, Glorieux G, Mullen W, Delles C, Verhamme P, Vanholder R, Staessen JA, Mischak H, Jankowski J.

Kidney Int Rep. 2017 Nov;2(6):1066-1075. doi: 10.1016/j.ekir.2017.06.004.

15.

Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy.

Krochmal M, Kontostathi G, Magalhães P, Makridakis M, Klein J, Husi H, Leierer J, Mayer G, Bascands JL, Denis C, Zoidakis J, Zürbig P, Delles C, Schanstra JP, Mischak H, Vlahou A.

Sci Rep. 2017 Nov 9;7(1):15160. doi: 10.1038/s41598-017-15359-9.

16.

Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients.

Markoska K, Pejchinovski M, Pontillo C, Zürbig P, Jacobs L, Smith A, Masin-Spasovska J, Stojceva-Taneva O, Polenakovic M, Magni F, Mischak H, Spasovski G.

Nephrol Dial Transplant. 2018 May 1;33(5):751-759. doi: 10.1093/ndt/gfx263.

PMID:
28992073
17.

A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population.

Zhang ZY, Ravassa S, Pejchinovski M, Yang WY, Zürbig P, López B, Wei FF, Thijs L, Jacobs L, González A, Voigt JU, Verhamme P, Kuznetsova T, Díez J, Mischak H, Staessen JA.

Kidney Int Rep. 2017 Sep;2(5):811-820. doi: 10.1016/j.ekir.2017.03.012.

18.

[Proteome analysis of undiluted vitreous humor in patients with branch retinal vein occlusion].

Dacheva I, Reich M, Nobl M, Ceglowska K, Wasiak J, Siwy J, Zürbig P, Mischak H, Koch FHJ, Kopitz J, Kretz FTA, Tandogan T, Auffarth GU, Koss MJ.

Ophthalmologe. 2018 Mar;115(3):203-215. doi: 10.1007/s00347-017-0469-z. German.

PMID:
28247073
19.

The use of urinary proteomics in the assessment of suitability of mouse models for ageing.

Nkuipou-Kenfack E, Schanstra JP, Bajwa S, Pejchinovski M, Vinel C, Dray C, Valet P, Bascands JL, Vlahou A, Koeck T, Borries M, Busch H, Bechtel-Walz W, Huber TB, Rudolph KL, Pich A, Mischak H, Zürbig P.

PLoS One. 2017 Feb 15;12(2):e0166875. doi: 10.1371/journal.pone.0166875. eCollection 2017.

20.

Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.

Lindhardt M, Persson F, Oxlund C, Jacobsen IA, Zürbig P, Mischak H, Rossing P, Heerspink HJL.

Nephrol Dial Transplant. 2018 Feb 1;33(2):296-303. doi: 10.1093/ndt/gfw406.

PMID:
28064163
21.

The long path towards implementation of clinical proteomics: Exemplified based on CKD273.

Nkuipou-Kenfack E, Zürbig P, Mischak H.

Proteomics Clin Appl. 2017 May;11(5-6). doi: 10.1002/prca.201600104. Epub 2017 Jan 17. Review.

PMID:
28019083
22.

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.

Siwy J, Zürbig P, Argiles A, Beige J, Haubitz M, Jankowski J, Julian BA, Linde PG, Marx D, Mischak H, Mullen W, Novak J, Ortiz A, Persson F, Pontillo C, Rossing P, Rupprecht H, Schanstra JP, Vlahou A, Vanholder R.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2079-2089. doi: 10.1093/ndt/gfw337.

23.

Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population.

Zhang ZY, Ravassa S, Yang WY, Petit T, Pejchinovski M, Zürbig P, López B, Wei FF, Pontillo C, Thijs L, Jacobs L, González A, Koeck T, Delles C, Voigt JU, Verhamme P, Kuznetsova T, Díez J, Mischak H, Staessen JA.

PLoS One. 2016 Dec 13;11(12):e0167582. doi: 10.1371/journal.pone.0167582. eCollection 2016.

24.

Urinary biomarkers for renal tract malformations.

Magalhães P, Schanstra JP, Carrick E, Mischak H, Zürbig P.

Expert Rev Proteomics. 2016 Dec;13(12):1121-1129. Epub 2016 Nov 15. Review.

25.

Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases.

Magalhães P, Mischak H, Zürbig P.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):494-501. Review.

26.

Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.

Lindhardt M, Persson F, Zürbig P, Stalmach A, Mischak H, de Zeeuw D, Lambers Heerspink H, Klein R, Orchard T, Porta M, Fuller J, Bilous R, Chaturvedi N, Parving HH, Rossing P.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1866-1873. doi: 10.1093/ndt/gfw292.

PMID:
27507891
27.

Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease.

Barrera-Ocampo A, Arlt S, Matschke J, Hartmann U, Puig B, Ferrer I, Zürbig P, Glatzel M, Sepulveda-Falla D, Jahn H.

J Neuropathol Exp Neurol. 2016 Sep;75(9):903-16. doi: 10.1093/jnen/nlw065. Epub 2016 Aug 2.

28.

A urinary proteome-based classifier for the early detection of decline in glomerular filtration.

Pontillo C, Jacobs L, Staessen JA, Schanstra JP, Rossing P, Heerspink HJL, Siwy J, Mullen W, Vlahou A, Mischak H, Vanholder R, Zürbig P, Jankowski J.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1510-1516. doi: 10.1093/ndt/gfw239.

PMID:
27387473
29.

Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism.

von Zur Mühlen C, Koeck T, Schiffer E, Sackmann C, Zürbig P, Hilgendorf I, Reinöhl J, Rivera J, Zirlik A, Hehrlein C, Mischak H, Bode C, Peter K.

Proteomics Clin Appl. 2016 May;10(5):574-84. doi: 10.1002/prca.201500105. Epub 2016 Apr 4.

PMID:
26898369
30.

Identification of ageing-associated naturally occurring peptides in human urine.

Nkuipou-Kenfack E, Bhat A, Klein J, Jankowski V, Mullen W, Vlahou A, Dakna M, Koeck T, Schanstra JP, Zürbig P, Rudolph KL, Schumacher B, Pich A, Mischak H.

Oncotarget. 2015 Oct 27;6(33):34106-17. doi: 10.18632/oncotarget.5896.

31.

Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria.

Øvrehus MA, Zürbig P, Vikse BE, Hallan SI.

Clin Proteomics. 2015 Aug 7;12(1):21. doi: 10.1186/s12014-015-9092-7. eCollection 2015.

32.

Urinary Proteome and Systolic Blood Pressure as Predictors of 5-Year Cardiovascular and Cardiac Outcomes in a General Population.

Zhang ZY, Thijs L, Petit T, Gu YM, Jacobs L, Yang WY, Liu YP, Koeck T, Zürbig P, Jin Y, Verhamme P, Voigt JU, Kuznetsova T, Mischak H, Staessen JA.

Hypertension. 2015 Jul;66(1):52-60. doi: 10.1161/HYPERTENSIONAHA.115.05296. Epub 2015 May 11.

PMID:
26063667
33.

Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.

Pejchinovski M, Hrnjez D, Ramirez-Torres A, Bitsika V, Mermelekas G, Vlahou A, Zürbig P, Mischak H, Metzger J, Koeck T.

Proteomics Clin Appl. 2015 Jun;9(5-6):453-68. doi: 10.1002/prca.201400113. Epub 2015 Apr 7. Review.

PMID:
25641766
34.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R.

J Am Soc Nephrol. 2015 Aug;26(8):1999-2010. doi: 10.1681/ASN.2014050423. Epub 2015 Jan 14.

35.

Proteome analysis in the assessment of ageing.

Nkuipou-Kenfack E, Koeck T, Mischak H, Pich A, Schanstra JP, Zürbig P, Schumacher B.

Ageing Res Rev. 2014 Nov;18:74-85. doi: 10.1016/j.arr.2014.09.002. Epub 2014 Sep 22. Review.

PMID:
25257180
36.

Left ventricular diastolic function in relation to the urinary proteome: a proof-of-concept study in a general population.

Zhang Z, Staessen JA, Thijs L, Gu Y, Liu Y, Jacobs L, Koeck T, Zürbig P, Mischak H, Kuznetsova T.

Int J Cardiol. 2014 Sep;176(1):158-65. doi: 10.1016/j.ijcard.2014.07.014. Epub 2014 Jul 12.

37.

The urinary proteome as correlate and predictor of renal function in a population study.

Gu YM, Thijs L, Liu YP, Zhang Z, Jacobs L, Koeck T, Zürbig P, Lichtinghagen R, Brand K, Kuznetsova T, Olivi L, Verhamme P, Delles C, Mischak H, Staessen JA.

Nephrol Dial Transplant. 2014 Dec;29(12):2260-8. doi: 10.1093/ndt/gfu234. Epub 2014 Jun 30.

PMID:
24981581
38.

Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.

Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés À, Lundin U, Weinberger KM, Dakna M, Delles C, Mullen W, Husi H, Klein J, Koeck T, Zürbig P, Mischak H.

PLoS One. 2014 May 9;9(5):e96955. doi: 10.1371/journal.pone.0096955. eCollection 2014.

39.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Siwy J, Schanstra JP, Argiles A, Bakker SJ, Beige J, Boucek P, Brand K, Delles C, Duranton F, Fernandez-Fernandez B, Jankowski ML, Al Khatib M, Kunt T, Lajer M, Lichtinghagen R, Lindhardt M, Maahs DM, Mischak H, Mullen W, Navis G, Noutsou M, Ortiz A, Persson F, Petrie JR, Roob JM, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Snell-Bergeon J, Spasovski G, Stojceva-Taneva O, Trillini M, von der Leyen H, Winklhofer-Roob BM, Zürbig P, Jankowski J.

Nephrol Dial Transplant. 2014 Aug;29(8):1563-70. doi: 10.1093/ndt/gfu039. Epub 2014 Mar 2.

40.

Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV).

Klein J, Lacroix C, Caubet C, Siwy J, Zürbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands JL, Decramer S, Schanstra JP.

Sci Transl Med. 2013 Aug 14;5(198):198ra106. doi: 10.1126/scitranslmed.3005807.

41.

IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.

Frantzi M, Zoidakis J, Papadopoulos T, Zürbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen W, Vlahou A.

J Proteome Res. 2013 Sep 6;12(9):3969-79. doi: 10.1021/pr400255h. Epub 2013 Aug 21.

PMID:
23924207
42.

Urine as a source for clinical proteome analysis: from discovery to clinical application.

Rodríguez-Suárez E, Siwy J, Zürbig P, Mischak H.

Biochim Biophys Acta. 2014 May;1844(5):884-98. doi: 10.1016/j.bbapap.2013.06.016. Epub 2013 Jul 2. Review.

PMID:
23831154
43.

High-resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.

Albalat A, Bitsika V, Zurbig P, Siwy J, Mullen W.

Methods Mol Biol. 2013;984:153-65. doi: 10.1007/978-1-62703-296-4_12.

PMID:
23386343
44.

Proteasix: a tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation.

Klein J, Eales J, Zürbig P, Vlahou A, Mischak H, Stevens R.

Proteomics. 2013 Apr;13(7):1077-82. doi: 10.1002/pmic.201200493. Epub 2013 Feb 26.

PMID:
23348921
45.

Use of proteomic methods in the analysis of human body fluids in Alzheimer research.

Zürbig P, Jahn H.

Electrophoresis. 2012 Dec;33(24):3617-30. doi: 10.1002/elps.201200360. Review.

PMID:
23160951
46.

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.

Roscioni SS, de Zeeuw D, Hellemons ME, Mischak H, Zürbig P, Bakker SJ, Gansevoort RT, Reinhard H, Persson F, Lajer M, Rossing P, Lambers Heerspink HJ.

Diabetologia. 2013 Feb;56(2):259-67. doi: 10.1007/s00125-012-2755-2. Epub 2012 Oct 20.

PMID:
23086559
47.

Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease.

Albalat A, Franke J, Gonzalez J, Mischak H, Zürbig P.

Methods Mol Biol. 2013;919:203-13. doi: 10.1007/978-1-62703-029-8_19.

PMID:
22976103
48.

Urinary proteomics for early diagnosis in diabetic nephropathy.

Zürbig P, Jerums G, Hovind P, Macisaac RJ, Mischak H, Nielsen SE, Panagiotopoulos S, Persson F, Rossing P.

Diabetes. 2012 Dec;61(12):3304-13. doi: 10.2337/db12-0348. Epub 2012 Aug 7.

49.

A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases.

Molin L, Seraglia R, Lapolla A, Ragazzi E, Gonzalez J, Vlahou A, Schanstra JP, Albalat A, Dakna M, Siwy J, Jankowski J, Bitsika V, Mischak H, Zürbig P, Traldi P.

J Proteomics. 2012 Oct 22;75(18):5888-97. doi: 10.1016/j.jprot.2012.07.024. Epub 2012 Jul 26.

PMID:
22842158
50.

Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis.

von zur Muhlen C, Schiffer E, Sackmann C, Zürbig P, Neudorfer I, Zirlik A, Htun N, Iphöfer A, Jänsch L, Mischak H, Bode C, Chen YC, Peter K.

Mol Cell Proteomics. 2012 Jul;11(7):M111.013847. doi: 10.1074/mcp.M111.013847. Epub 2012 Feb 27.

Supplemental Content

Loading ...
Support Center